Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT05643092
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be ≥ 18 years of age at signing of informed consent.
* Subjects are scheduled to receive CAR T-cell treatment.
Exclusion Criteria:
* Refusal to sign the informed consent
* Subjects having previously been treated with CAR-T therapy.
* Subjects with clinically significant active bleeding, history of intracranial bleeding, or is at risk for intracranial bleeding
* Subjects presenting primary CNS lymphoma
* Pacemaker or other implanted electrical device incompatible with the MR environment
* Subjects with a neurodegenerative disease (PD, AD)
* Subjects with a previous or evolving neurological pathology
* Pregnant or breastfeeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05643092
Study Brief:
Protocol Section:
NCT05643092